United States v. Robert Louis Boettjer

569 F.2d 1078
CourtCourt of Appeals for the Ninth Circuit
DecidedApril 17, 1978
Docket77-1225
StatusPublished
Cited by17 cases

This text of 569 F.2d 1078 (United States v. Robert Louis Boettjer) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Robert Louis Boettjer, 569 F.2d 1078 (9th Cir. 1978).

Opinion

PALMIERI, District Judge:

The appellant, Dr. Boettjer, a registered physician licensed to practice medicine in California, was convicted after a five day jury trial on seven counts of an indictment charging him with the unauthorized distribution and attempted distribution of controlled substances in violation of 21 U.S.C. § 841 and 21 U.S.C. § 846. 1 He was sentenced to two years imprisonment on each count, to run concurrently, in addition to a fine of $15,000 payable over five years. Execution of the sentence was suspended and he was placed on probation for a period of five years. A special parole term of two years was also imposed as to each count, to run concurrently. Error is alleged with respect to the District Court’s instruction to the jury on the elements of the crime charged and its refusal to give certain instructions requested by the appellant. We affirm.

I.

Between March 12, 1976 and May 3, 1976 three part-time investigators of the Drug Enforcement Administration made a number of visits to the appellant’s office, representing themselves as patients, and sought prescriptions for methaqualone (a depressant, commonly known as quaalude) and methylphenidate (a stimulant, commonly known as ritalin). As part of their training they had been instructed not to offer any medical reasons for the prescription of these drugs. After conducting interviews, Dr. Boettjer issued a number of prescriptions for the requested drugs. The substance of these consultations was a matter as to which there was conflicting testimony at trial.

Although the sufficiency of the evidence is not challenged by the appellant, a brief review of the government’s case is instructive. The three investigators provided the bulk of the evidence against Dr. Boettjer. They testified that upon their visits to the doctor’s office they asked for the controlled substances by name, not complaining of any insomnia, depression, or any other condition requiring medical attention, but rather requesting the drugs because they were “out of them”, “liked them”, “needed a refill”, “it picked me up”, and so on. The doctor performed only the most casual physical examinations, in some cases weighing the patient fully dressed and taking blood pressure readings through the patient’s clothing. There was evidence that Dr. Boettjer made no professional appointments, but received his callers on a first-come, first-serve basis, the priority of their visits being regulated by the order of their signatures on a sheet of paper attached to a clipboard; that very few of the visits lasted more than about five minutes; and that the doctor’s established charge was $25 for a first visit and $12 for subsequent visits.

The testimony of the government’s expert witness, Dr. Forrest S. Tennant, a chemist and medical doctor with distinguished professional credentials, supported the conclusion that Dr. Boettjer had dealt with the investigator-patients in an unprofessional manner without the application of sound medical criteria and that the prescriptions were not issued for legitimate medical purposes.

While the appellant testified in his own behalf and sought to cast a very different *1080 light upon his activities, the guilty verdict stands — given a properly instructed jury— as a rejection of his testimony.

II.

21 U.S.C. § 841(a)(1) makes it a crime for any person “knowingly or intentionally to . distribute, or dispense . a controlled substance,” “except as authorized by this subchapter.” Persons who are properly registered with the Attorney General are authorized to distribute and dispense controlled substances “in conformity with the other provisions of this subehap-ter.” 21 U.S.C. § 822(b). It was stipulated at trial that Dr. Boettjer was a registered physician who was authorized to dispense controlled substances for legitimate medical purposes.

Quaalude and ritalin have both been classified by the Attorney General as Schedule II controlled substances. 21 C.F.R. § 1308.-12. Schedule II substances are drugs which have a “high potential for abuse,” and which may lead to “severe psychological or physical dependence,” but which nonetheless have a “currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions.” 21 U.S.C. § 812(b)(2). It was stipulated at trial that the drugs which Dr. Boettjer prescribed were in fact these controlled substances.

No controlled substance in Schedule II may be dispensed without the written prescription of a practitioner 2 , subject to certain exceptions not relevant here. 21 U.S.C. § 829(a). In order for a prescription for any controlled substance to be effective it “must be issued for a legitimate medical purpose by an individual practitioner acting in the usual course of his professional practice.” 21 C.F.R. § 1306.04(a). It is well established that prescriptions not satisfying the requirements of this regulation, if knowingly or intentionally issued, may form the predicate for a practitioner’s criminal liability under 21 U.S.C. § 841. United States v. Rosenberg, 515 F.2d 190 (9th Cir. 1975), cert. denied, 423 U.S. 1031, 96 S.Ct. 562, 46 L.Ed.2d 404 (1975); United States v. Green, 511 F.2d 1062, 1070 (7th Cir. 1975), cert. denied, 423 U.S. 1031, 96 S.Ct. 561, 46 L.Ed.2d 404 (1975); United States v. Larsen, 507 F.2d 385 (9th Cir. 1974). It is also established that registered physicians are not immune from prosecution under 21 U.S.C. § 841 when their activities fall outside the usual course of professional practice. United States v. Moore, 423 U.S. 122, 96 S.Ct. 335, 46 L.Ed.2d 333 (1975).

III.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Julio Diaz
Ninth Circuit, 2017
United States v. Michael Minas
697 F. App'x 531 (Ninth Circuit, 2017)
United States v. Smith
573 F.3d 639 (Eighth Circuit, 2009)
United States v. Jeffrey H. Feingold
454 F.3d 1001 (Ninth Circuit, 2006)
United States v. Feingold
Ninth Circuit, 2006
United States v. Prejean
429 F. Supp. 2d 782 (E.D. Louisiana, 2006)
Oregon v. Ashcroft
192 F. Supp. 2d 1077 (D. Oregon, 2002)
United States v. Mesfin Seyoum
943 F.2d 56 (Ninth Circuit, 1991)
State v. Young
406 S.E.2d 758 (West Virginia Supreme Court, 1991)
United States v. Jude R. Hayes
794 F.2d 1348 (Ninth Circuit, 1986)
United States v. Shiva N. Varma
691 F.2d 460 (Tenth Circuit, 1982)
United States v. Roosevelt Peter Jackson
576 F.2d 46 (Fifth Circuit, 1978)

Cite This Page — Counsel Stack

Bluebook (online)
569 F.2d 1078, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-robert-louis-boettjer-ca9-1978.